Roquefort Investments PLC (GB:ROQ) has released an update.
Roquefort Therapeutics PLC, a biotech firm specializing in innovative immuno-oncology medicines, has announced its upcoming Annual General Meeting (AGM), which will be held at Reynolds Porter Chamberlain LLP in London on June 27, 2024. The company, which is listed on both LSE and OTCQB, has made the AGM notice and proxy forms available on their website. Roquefort’s portfolio features five pre-clinical, patent-protected, anti-cancer drugs, showcasing a diverse and potentially groundbreaking approach to cancer treatment.
For further insights into GB:ROQ stock, check out TipRanks’ Stock Analysis page.
